NEW YORK (GenomeWeb News) – Crescendo Bioscience today announced it has received clearance from New York to provide services to patients in the state. As a result, the company can now offer its rheumatoid arthritis test in New York.

The Wadsworth Center at the New York Department of Health, through its Clinical Laboratory Evaluation Program, issued a laboratory permit to the company. With today's approval, Crescendo Bio can now offer its test, called Vectra DA, in all 50 states in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.